Arista Biologicals
COVID-19 Nucleocapsid Colloidal Gold Conjugated
Catalog #CGCOV-0632
ApplicationLFA
CGCOV-0632
Bulk quantities and custom vialing available.
Product Description
Recombinant antigen, colloidal gold conjugated (40 nm, 10 µg/mL), delivers strong visual signals for high-performance LFA infectious disease and POC COVID-19 screening.
Specifications
Conjugate Type
Colloidal Gold
Target Identity
Antigen Species
SARS-CoV-2
Product Information
Application
LFA
Buffer
50 mM PBS with 1% BSA and 0.1% Sodium Azide, pH 7.4
Storage
2 - 8 °C
Physical State
Liquid
Shelf Life
30 days from date of receipt
Country of Origin
USA
Applications
Not for human, therapeutic, or in-vivo use. For research and further manufacturer use only.
Related Products
Services
Need a different format?
Custom purification, concentration or buffer formulation, built to your specifications.
Request Customization
Need LFA development support?
Process development, manufacturing from feasibility through commercial production
Request Customization
Need a custom gold nanoparticle?
Need custom Gold nanoparticles? Various sizes, shapes, surface modifications, and custom options.
Request Customization
Resources
Control Line Systems for Lateral Flow Assays
Read the Article
Lateral Flow Assay Development Guide
Read the Guide
Enhancing Sensitivity in Lateral Flow Assays Using Passively Conjugated Gold Nanoshells
Read the Article
Flexible product configurations, and scalable supply.
Purpose-designated for capture, detection, or both in rapid-test development.
Bulk quantities, custom formulations and gold conjugation option are available to support your projects needs.